Brief: Passage Bio Reports Fourth Quarter And Full-Year 2021 Financial Results

Passage Bio

03/03/2022 12:58

March 3 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO REPORTS FOURTH QUARTER AND FULL-YEAR 2021
FINANCIAL
RESULTS AND PROVIDES RECENT BUSINESS HIGHLIGHTS
    * Q4 LOSS PER SHARE $0.95
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$315.8
MILLION AS OF DECEMBER 31, 2021
    * EXPECTS CURRENT CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
TO FUND OPERATIONS TO YEAR-END 2023

Source text for Eikon:  ID:nGNX33qVyN 
Further company coverage:  PASG.O 

 ((Reuters.Briefs@thomsonreuters.com;))